Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Mutation in AIDS restriction gene affecting HIV infection and disease progression in a high risk group from Northeastern India.

Roy P, Chakrabarti S.

Med J Armed Forces India. 2016 Apr;72(2):111-5. doi: 10.1016/j.mjafi.2015.07.005. Epub 2016 Feb 6.

2.
3.

The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.

Sullivan AD, Wigginton J, Kirschner D.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10214-9. Epub 2001 Aug 21.

4.

HIV infection and host genetic mutation among injecting drug-users of northeastern states of India.

Sarkar K, Das SS, Pal R, Bal B, Madhusudan P, Chakraborti S.

J Health Popul Nutr. 2010 Apr;28(2):130-6.

5.

Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.

Rathore A, Chatterjee A, Sivarama P, Yamamoto N, Singhal PK, Dhole TN.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1149-56. doi: 10.1089/aid.2008.0019.

PMID:
19886839
6.

Association of IL-4 589 C/T promoter and IL-4RalphaI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians.

Chatterjee A, Rathore A, Dhole TN.

J Med Virol. 2009 Jun;81(6):959-65. doi: 10.1002/jmv.21478.

PMID:
19382262
7.

Low frequency of the ccr5delta32 HIV-resistance allele in mainland China: identification of the first case of ccr5delta32 mutation in the Chinese population.

Jiang JD, Wang Y, Wang ZZ, Chen XH, Guo ZM, Pan HL, Bekesi GJ, Wang AX, Chen HS.

Scand J Infect Dis. 1999;31(4):345-8.

PMID:
10528870
8.

Risk for HIV-1 infection is not associated with repeat-region polymorphism in the DC-SIGN neck domain and novel genetic DC-SIGN variants among North Indians.

Rathore A, Chatterjee A, Sood V, Khan SZ, Banerjea AC, Yamamoto N, Dhole TN.

Clin Chim Acta. 2008 May;391(1-2):1-5. doi: 10.1016/j.cca.2007.12.019. Epub 2008 Jan 12.

PMID:
18255039
9.

The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.

Gharagozloo M, Doroudchi M, Farjadian S, Pezeshki AM, Ghaderi A.

Immunol Lett. 2005 Jan 31;96(2):277-81.

PMID:
15585333
10.

Frequency of CCR5Δ32 allele in healthy Bosniak population.

Adler G, Valjevac A, Skonieczna-Żydecka K, Mackic-Djurovic M, Parczewski M, Urbańska A, Salkic NN.

Bosn J Basic Med Sci. 2014 Aug 28;14(3):150-4. doi: 10.17305/bjbms.2014.3.102.

11.

Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.

Li C, Yan YP, Shieh B, Lee CM, Lin RY, Chen YM.

J Formos Med Assoc. 1997 Dec;96(12):979-84.

PMID:
9444918
12.

Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression.

Knuchel MC, Spira TJ, Neumann AU, Xiao L, Rudolph DL, Phair J, Wolinsky SM, Koup RA, Cohen OJ, Folks TM, Lal RB.

AIDS Res Hum Retroviruses. 1998 Mar 1;14(4):305-9.

PMID:
9519891
13.

CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group.

Misrahi M, Teglas JP, N'Go N, Burgard M, Mayaux MJ, Rouzioux C, Delfraissy JF, Blanche S.

JAMA. 1998 Jan 28;279(4):277-80.

PMID:
9450710
14.

Human leukocyte antigen B distribution in HIV discordant cohort from India.

Chaudhari DV, Chavan VR, Ahir SP, Kerkar SC, Mehta PR, Mania-Pramanik J.

Immunol Lett. 2013 Nov-Dec;156(1-2):1-6. doi: 10.1016/j.imlet.2013.09.002. Epub 2013 Sep 9.

PMID:
24029662
15.

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study.

McDermott DH, Beecroft MJ, Kleeberger CA, Al-Sharif FM, Ollier WE, Zimmerman PA, Boatin BA, Leitman SF, Detels R, Hajeer AH, Murphy PM.

AIDS. 2000 Dec 1;14(17):2671-8.

PMID:
11125885
16.

Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.

Kim A, Pettoello-Mantovani M, Goldstein H.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):145-9.

PMID:
9768623
17.

High prevalence of the CCR5Delta32 HIV-resistance mutation among Estonian HIV type 1-infected individuals.

Adojaan M, Mölder T, Männik A, Kivisild T, Villems R, Krispin T, Ustav M.

AIDS Res Hum Retroviruses. 2007 Feb;23(2):193-7.

PMID:
17331026
18.

CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.

Oh DY, Jessen H, Kücherer C, Neumann K, Oh N, Poggensee G, Bartmeyer B, Jessen A, Pruss A, Schumann RR, Hamouda O.

PLoS One. 2008 Jul 23;3(7):e2747. doi: 10.1371/journal.pone.0002747.

19.

[Frequency of the mutated allele of CCR-5 receptor in HIV-1 positive and negative individuals in the Province of Chaco].

Motta P, Cibulsky L, Iliovich E, Habegger de Sorrentino A.

Medicina (B Aires). 2000;60(4):431-4. Spanish.

PMID:
11188946
20.

No Association between the CCR5Δ32 Polymorphism and Sporadic Esophageal Cancer in Punjab, North-West India.

Sambyal V, Manjari M, Sudan M, Uppal MS, Singh NR, Singh H, Guleria K.

Asian Pac J Cancer Prev. 2015;16(10):4291-5.

Supplemental Content

Support Center